scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1042693136 |
P356 | DOI | 10.2165/00003088-198712020-00002 |
P698 | PubMed publication ID | 3549104 |
P2093 | author name string | K W Woodhouse | |
H Wynne | |||
P2860 | cites work | Salicylate accumulation kinetics in man | Q28249630 |
Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans | Q28294653 | ||
Non-oliguric renal failure during treatment with mefenamic acid in elderly patients: a continuing problem | Q28362367 | ||
Pharmacokinetics of ketoprofen in the elderly | Q34512945 | ||
The effect of ageing on the hepatic clearance of propranolol | Q34517399 | ||
Aspirin metabolism and efficacy in postoperative dental pain | Q34621226 | ||
Naproxen pharmacokinetics in the elderly | Q34621473 | ||
The disposition of sulindac | Q34684315 | ||
Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac | Q34695329 | ||
Benoxaprofen: side-effect profile in 300 patients. | Q34759595 | ||
Fatal cholestatic jaundice in elderly patients taking benoxaprofen. | Q34759664 | ||
The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesis | Q39156132 | ||
Drugs and the ageing gut, liver and pancreas | Q39415334 | ||
Piroxicam Pharmacokinetics in Man: Aspirin and Antacid Interaction Studies | Q39558510 | ||
Clinical Pharmacokinetics of indomethacin | Q39567269 | ||
Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent Voltaren | Q39615797 | ||
Comparative disposition of sulindac and metabolites in five species | Q39638427 | ||
Clinical Pharmacokinetics of Phenylbutazone | Q39773902 | ||
Clinical significance of esterases in man. | Q39829565 | ||
Alterations in the liver with ageing. | Q39839015 | ||
Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disorders | Q40006961 | ||
Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs | Q40157661 | ||
Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium | Q40327847 | ||
Defective oxidation of drugs: pharmacokinetic and therapeutic implications | Q40329696 | ||
Preliminary studies of absorption and excretion of benoxaprofen in man | Q40659320 | ||
Disposition and Metabolism of Benoxaprofen in Laboratory Animals and Man | Q41416983 | ||
Pharmacokinetics of Salicylates in Elderly | Q41494121 | ||
The influence of age on the pharmacokinetics of paracetamol [proceedings] | Q41606702 | ||
Digoxin in the elderly: Pharmacokinetic consequences of old age | Q41617375 | ||
Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation | Q41861859 | ||
Transsynovial distribution of ibuprofen in arthritic patients | Q42274287 | ||
Pharmacokinetics of indomethacin | Q42597265 | ||
Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay | Q42671028 | ||
Pharmacokinetics of azapropazone in the elderly | Q42739047 | ||
The effect of vitamin supplementation upon antipyrine metabolism in the elderly | Q43251770 | ||
Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients | Q43261977 | ||
Nonlinear plasma level response to high doses of naproxen | Q47886452 | ||
Effect of Age and Sex on Human Drug Metabolism | Q50348052 | ||
Pharmacokinetic studies of benoxaprofen in geriatric patients. | Q51652496 | ||
The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration. | Q51655959 | ||
Biopharmaceutical assessment of phenylbutazone and indomethacin preparations. | Q53761127 | ||
The binding of indomethacin, salicylate and phenobarbitone to human whole blood in vitro. | Q54586946 | ||
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. | Q54797299 | ||
Effects of aspirin and acetaminophen in gastrointestinal hemorrhage. Results from the Boston Collaborative Drug Surveillance Program | Q57946016 | ||
Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease | Q59525256 | ||
Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol) | Q66987957 | ||
Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking | Q67273626 | ||
Naproxen-metabolism, excretion and comparative pharmacokinetics | Q67273846 | ||
Absorption kinetics of aspirin in man following oral administration of an aqueous solution | Q67300357 | ||
Pharmacokinetics in the elderly | Q67396499 | ||
Aging and ethanol metabolism | Q67548911 | ||
Disposition of pirprofen, a new anti-inflammatory drug | Q67575105 | ||
Disposition and oxidative metabolism of phenylbutazone in man | Q67594631 | ||
The effect of ageing on drug absorption from the gut | Q67669312 | ||
Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro | Q68803909 | ||
The metabolism of indomethacin in man | Q69180079 | ||
Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years | Q69377354 | ||
Naproxen Oral Absorption Characteristics | Q69391961 | ||
Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study | Q69596139 | ||
Pharmacokinetics of pirprofen in young volunteers and elderly patients | Q69874385 | ||
Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer | Q69877679 | ||
Rising frequency of ulcer perforation in elderly people in the United Kingdom | Q69877701 | ||
The effect of age on pathways of drug metabolism in human liver | Q70231205 | ||
Sulindac disposition when given once and twice daily | Q70252808 | ||
Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions--2 | Q70288264 | ||
The pharmacokinetics of benoxaprofen in elderly subjects | Q70369735 | ||
Absorption and disposition of ibuprofen in the elderly | Q70612534 | ||
Vancomycin disposition: the importance of age | Q70670631 | ||
The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver | Q71006211 | ||
Gastrointestinal and liver function of old age | Q71032820 | ||
Haematological and biochemical laboratory values in an ambulatory elderly population: an analysis of the effects of age, sex and drugs | Q71160662 | ||
Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration | Q71397265 | ||
Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals | Q71705871 | ||
Drug distribution and renal excretion in the elderly | Q71728184 | ||
Increased serum salicylate metabolites with age in patients receiving chronic acetylsalicylic acid therapy | Q72098454 | ||
Capacity-Limited Salicylurate Formation During Prolonged Administration of Aspirin to Healthy Human Subjects | Q72394299 | ||
Metabolism of piroxicam by laboratory animals | Q72475136 | ||
Jaundice associated with the use of benoxaprofen | Q72526111 | ||
Gastric and duodenal ulcer. The association between aspirin ingestion, smoking and family history of ulcer | Q72532420 | ||
Metabolism of pirprofen in man, monkey, rat, and mouse | Q72539175 | ||
Comparative steady state pharmacokinetic study of piroxicam and flurbiprofen in normal subjects | Q72841712 | ||
Age differences in the water content of the body as related to basal oxygen consumption in males | Q79666551 | ||
Salicylate kinetics in old age | Q93571509 | ||
P433 | issue | 2 | |
P921 | main subject | pharmacokinetics | Q323936 |
inflammation | Q101991 | ||
P304 | page(s) | 111-122 | |
P577 | publication date | 1987-02-01 | |
P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
P1476 | title | The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly | |
P478 | volume | 12 |
Q36485541 | Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics |
Q34512204 | Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells |
Q33937522 | Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach |
Q45280007 | Clearance of indomethacin occurs predominantly by renal glucuronidation |
Q34311477 | Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly |
Q44614902 | Disposition of flurbiprofen in man: influence of stereochemistry and age |
Q35170409 | Do the pharmacodynamics of the nonsteroidal anti-inflammatory drugs suggest a role in the management of postoperative pain? |
Q39522004 | Drug metabolism in the elderly |
Q69665194 | Effect of age on the pharmacokinetics of dipyrone |
Q36724175 | Elderly people taking non-steroidal anti-inflammatory drugs are unlikely to have excess renal impairment |
Q34531655 | Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib |
Q35825392 | Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers |
Q36282905 | Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects |
Q68506534 | Nonsteroidal anti-inflammatory drugs |
Q36122786 | Nonsteroidal anti-inflammatory drugs alter vasa recta diameter via pericytes |
Q50960420 | Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics. |
Q34171491 | Pain in nursing home residents: management strategies |
Q36148700 | Pain management for dentists: the role of ibuprofen. |
Q40425454 | Pharmacokinetic Optimisation of Drug Therapy in Elderly Patients |
Q40758038 | Pharmacokinetic optimisation of the treatment of osteoarthritis |
Q35277247 | Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteers |
Q70743653 | Pharmacokinetics of indomethacin in the elderly |
Q68057834 | Pharmacokinetics of pirazolac, a new anti-inflammatory drug, in human volunteers. III. Steady state plasma levels |
Q34358409 | Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy young and elderly subjects: comparison with elderly rheumatic patients |
Q77733092 | Renal hemodynamic effects of nabumetone, sulindac, and placebo in patients with osteoarthritis |
Q40919271 | Selective inhibitors of cyclooxygenase-2. Potential in elderly patients |
Q33973162 | Systematic review: is the use of NSAIDs effective and safe in the elderly? |
Q36972832 | The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)1 |
Q34345908 | The pharmacokinetics of piroxicam in elderly persons with and without renal impairment |
Q41526041 | Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor? |
Q67834984 | Unaltered ibuprofen-induced faecal blood loss upon coadministration of moclobemide |